Equity

IHE

iShares U.S. Pharmaceuticals ETF

Add to Compare
  • NAV as of 20/Feb/2026 USD 89.80
    52 WK: 60.94 - 90.46
  • 1 Day NAV Change as of 20/Feb/2026 USD -0.66 (-0.72%)
  • NAV Total Return as of 20/Feb/2026 YTD: 5.93%
  • Morningstar Rating
  • Fees as stated in the prospectus Expense Ratio: 0.38%

Overview

Why IHE?

1. Exposure to U.S. companies that manufacture prescription or over-the-counter drugs or vaccines

 

2. Targeted access to domestic pharmaceutical stocks

 

3. Use to express a sector view

INVESTMENT OBJECTIVE

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.

Important Information: Capital at Risk. The value of investments and the income from them can fall as well as rise and are not guaranteed. Investors may not get back the amount originally invested.

Show Less
Loading